feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Technology / CES: Korean Startup Revolutionizes Brain Therapy

CES: Korean Startup Revolutionizes Brain Therapy

9 Jan

•

Summary

  • Phin Stim uses flexible electrodes to gently treat brain conditions.
  • The device helps correct irregular brain signals for conditions like epilepsy.
  • Gbrain focuses on practical medical applications, not futuristic claims.
CES: Korean Startup Revolutionizes Brain Therapy

Korean neurotechnology startup Gbrain is presenting its Phin Stim system at CES 2026, offering advanced medical solutions for brain disorders. This innovative device targets neurological conditions by delivering precise electrical stimulation to correct irregular brain signals. The technology utilizes ultrathin, flexible electrodes that conform to the brain's surface, enhancing signal quality and minimizing irritation, a significant advancement over rigid implants.

Gbrain's Phin Stim is designed to help patients with conditions such as epilepsy and Parkinson's disease. The system monitors brain activity and intervenes to guide neural pathways back to healthier patterns. While a fully implantable system is the long-term goal, current versions are undergoing clinical trials and regulatory review in Korea, with a prototype recognized as a CES 2025 Innovation Awards Honoree and an updated version for CES 2026.

The company emphasizes practical medical applications over speculative claims, focusing on improving patients' daily lives rather than pursuing enhancement or mind-reading technologies. Gbrain's measured approach highlights manufacturing standards, clinical validation, and regulatory pathways, signaling a commitment to transforming technology into tangible treatments for those in need.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Phin Stim is a neurotechnology device from Gbrain designed to treat neurological conditions using precise electrical brain stimulation.
It corrects irregular brain signals with flexible electrodes, aiming to minimize symptoms for conditions like epilepsy and Parkinson's disease.
Gbrain focuses on practical medicine, offering grounded tools for clinicians to help patients, rather than speculative futuristic enhancements.

Read more news on

Technologyside-arrow
trending

Unemployment rate dipped to 4.4%

trending

ASTS satellites defense communication growth

trending

Meta invests in Oklo stock

trending

US jobs data Friday

trending

Pakistan leads series against SriLanka

trending

Frore Systems demos Liquidjet

trending

Las Vegas freeze warning issued

trending

Jon-Eric Sullivan to Dolphins

trending

Cubs sign Edward Cabrera

You may also like

Brain Wearables: What Doctors Really Say

7 Jan • 10 reads

article image

Simple Blood Test May Detect Alzheimer's Early

5 Jan • 48 reads

article image

Jo Whiley Faces Challenging Christmas with Sick Parents

15 Dec, 2025 • 142 reads

article image

Teen denied 'miracle drug' in postcode lottery

10 Dec, 2025 • 168 reads

article image

Parkinson's Patients Conquer Heights in Adaptive Climbing

4 Dec, 2025 • 158 reads

article image